Effects of losartan/diuretic combination treatment on serum uric acid levels in hypertensive patients

被引：9

作者：

Milionis, HJ

Nikas, S

Elisaf, MS

机构：

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 09期

关键词：

D O I：

10.1016/S0002-9149(01)01959-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1084 / 1084

页数：1

共 9 条

[1]

Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4

[2]

Edwards RM, 1996, J PHARMACOL EXP THER, V276, P125

[3] Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia [J].

Elisaf, M ;

Tsimichodimos, V ;

Bairaktari, E ;

Siamopoulos, KC .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 (01) :60-63

[4] Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: Case histories [J].

Milionis, HJ ;

Elisaf, MS .

CURRENT MEDICAL RESEARCH AND OPINION, 2000, 16 (03) :164-170

[5]

NAKASHIMA M, 1992, EUR J CLIN PHARMACOL, V42, P333

[6]

Nikas S, 2000, J Renin Angiotensin Aldosterone Syst, V1, P289, DOI 10.3317/jraas.2000.045

[7] Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension [J].

Oparil, S ;

Aurup, P ;

Snavely, D ;

Goldberg, A .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (06) :721-726

[8] Safely of losartan in hypertensive patients with thiazide-induced hyperuricemia [J].

Shahinfar, S ;

Simpson, RL ;

Carides, AD ;

Thiyagarajan, B ;

Nakagawa, Y ;

Parks, JH ;

Coe, FL .

KIDNEY INTERNATIONAL, 1999, 56 (05) :1879-1885

[9] Uric acid as an independent risk factor in the treatment of hypertension [J].

Ward, HJ .

LANCET, 1998, 352 (9129) :670-671

← 1 →